NCT07160127View on ClinicalTrials.gov

A Clinical Study of Chinese Herbal Formula TJAOA103 in Treating Genitourinary Syndrome of Menopause

EARLY_PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

113

Participants

Timeline

Start Date

September 15, 2025

Primary Completion Date

June 15, 2027

Study Completion Date

September 15, 2027

Conditions
Genitourinary Syndrome of Menopause (GSM)
Interventions
DRUG

TJAOA103

Once enrolled, participants will be administered TJAOA103 for 4 to 12 weeks. TJAOA103 should be taken orally twice a day, one sack each time. Dissolve it in about 200 mL of warm water and drink it all. Participants can take it half an hour before breakfast in the morning and half an hour before bedtime in the evening.

Trial Locations (1)

Unknown

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

All Listed Sponsors
lead

Tongji Hospital

OTHER